Blog

RSS Feed
Posted by Michael Wonder on 23 Sep 2021

Canada should negotiate a fairer share of drug R&D costs

23 September 2021 - Instead of relying on price regulation, Canada should engage in negotiations about drug pricing. ...

Read more →
Posted by Michael Wonder on 16 Sep 2015

German drug companies are criticised for not focusing on useful therapeutic areas

15 September 2015 - A 2011 German law designed to lower prices of new innovative drugs has not been as successful ...

Read more →
Posted by Michael Wonder on 04 Sep 2015

NICE joins project to make development of new treatments more efficient

4 September 2015 - Called the Accelerated Development of Appropriate Patient Therapies (ADAPT SMART), and funded by the EU Innovative Medicines ...

Read more →